Understanding Recent Medicare and Medicaid Reimbursement Developments

Healthcare reimbursement continues to evolve rapidly, with recent and proposed rulemaking introducing meaningful changes across Medicare inpatient and outpatient payment systems, Medicare Advantage, and Medicaid supplemental payments. For hospitals and health systems, understanding how these updates intersect is critical to financial planning, compliance, and long-term sustainability.

Recent updates to the IPPS Final Rule, OPPS Rule, Medicare Advantage policies, and Medicaid payment frameworks reflect a period of heightened scrutiny and tightening margins. While some provisions offer modest payment increases, others introduce operational and financial pressures that organizations will need to manage carefully.

Medicare Inpatient Reimbursement and Quality Updates

Under the IPPS Final Rule, hospitals will see a federal payment rate increase driven by a market basket update, partially offset by productivity adjustments. While the net increase provides some relief, it may not fully offset rising labor and operating costs, particularly for organizations already under financial strain. Changes to Medicare Severity Diagnosis-Related Groups (MS-DRGs), including new classifications and the elimination of certain existing categories, may also affect case mix index calculations and revenue forecasting.

Several additional inpatient-related policy changes warrant attention, including:

• The introduction of the Transforming Episode Accountability Model (TEAM), a bundled payment initiative for select surgical procedures beginning January 1, with limited downside risk for lower-volume hospitals.
• Expanded Extraordinary Circumstances Exception (ECE) relief, extending filing deadlines from 90 to 180 days and allowing exceptions to apply on a measure-by-measure basis for up to three years.
• Updates to quality reporting requirements, including the removal of certain health equity measures and a growing emphasis on nutrition and wellness outcomes.
• Wage index policy adjustments, including the discontinuation of the Low-Wage Index Hospital Policy, limited relief for significant decreases, and continued scrutiny of urban-to-rural reclassifications.

Together, these changes may influence inpatient reimbursement, compliance expectations, and financial planning, particularly for hospitals with complex case mixes or exposure to wage index volatility.

Uncompensated Care and Program Funding Pressures

Funding for uncompensated care has increased substantially, providing additional support for hospitals serving uninsured and underinsured populations. However, providers should closely monitor trends in uninsured volumes, particularly as exchange subsidies are scheduled to expire. These expenditures could contribute to increased uncompensated care and further pressure hospital margins.

At the same time, Medicare Dependent Hospital and Low-Volume Hospital programs are scheduled to expire. While past extensions suggest future legislative action is possible, uncertainty remains. The potential loss of these programs could have material financial implications for hundreds of hospitals nationwide.

Outpatient and Medicare Advantage Reimbursement Trends

The OPPS Rule reflects only a modest net payment increase once wage adjustments, drug administration reductions, and 340B recoupment adjustments are considered. Despite headline increases, the combined effect results in limited overall financial relief for providers.

Outpatient and Medicare Advantage reimbursement trends continue to introduce pressure through:

• Ongoing scrutiny of the Two-Midnight Rule, particularly as it applies to Medicare Advantage plans.
• Increased reliance on accurate inpatient day reporting, which affects cost reports and reimbursement calculations.
• Reductions in payments for drug administration services in off-campus provider-based departments reinforce the move toward site-neutral payment policies.
• New Medicare Advantage requirements aimed at reducing post-approval denials and expanding inclusion of MA beneficiaries in traditional Medicare quality measures.

In addition, the 340B program faces growing administrative and cash flow challenges. Accelerated recoupment of prior settlement amounts and proposed pilot programs requiring upfront drug payments followed by manufacturer rebates may increase operational complexity for participating providers.

Medicaid Supplemental Payments and State-Level Changes

Medicaid supplemental payment structures are undergoing significant changes. Provider tax safe-harbor limits will phase down over time in expansion states, while non-expansion states may retain existing arrangements. For providers without current taxes in place, new rules effectively prohibit the implementation of hold-harmless arrangements.

State-directed payments will also face tighter caps tied to Medicare rates, requiring states with higher existing payment levels to gradually reduce them. New uniformity requirements further narrow the circumstances under which provider tax waivers may be granted, increasing compliance complexity and financial exposure for providers and states alike.

Preparing for What Comes Next

Taken together, these reimbursement updates point to a broader trend of tightening margins, increased oversight, and growing administrative demands. Healthcare organizations will need to evaluate how these changes affect revenue streams, cost structures, and long-term planning efforts across service lines and payer mixes.

If you have questions about how recent Medicare and Medicaid reimbursement changes may impact your organization, or if you would like assistance evaluating financial exposure and planning strategies, contact your CRI advisor. Proactive analysis and informed decision-making can help healthcare providers navigate these changes with greater confidence and resilience.